MIMETAS

Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlateĀ®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.